CLINICAL, LABORATORY FEATURES AND RESULTS OF PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH MULTIVESSEL CORONARY ARTERY DISEASE AT CAN THO CENTRAL GENERAL HOSPITAL

Binh Dang Nguyen 1, , Thu Thuy Pham 1, Trung Cang Huynh2
1 Can Tho University of Medicine and Pharmacy
2 Kien Giang General hospital

Main Article Content

Abstract

Background: the rate of multivessel coronary artery disease is remarkably high. Objectives: to investigate the clinical, laboratory characteristics, several risk factors and the results of percutaneous coronary intervention in patients with multivessel coronary artery disease. Materials and method: patients with multiple coronary artery disease treated by percutaneous coronary intervention in multiple coronary artery at Can Tho Central General Hospital from 04/2020 to 12/2020. Results: the leading cardiovascular risk factor was hypertension with 82%, followed by diabetes at 24%. Typical angina pectoris accounted for 74%, acute myocardial infarction saw the highest percentage at 84% among all types of multivessel coronary artery disease and Killip I was 85.7%. Most electrocardiograms showed signs of myocardial ischemia or infarction, at 86%. Echocardiography recorded intermediate to preserved ejection fractions in 82% of the cases, the most common regional movement disorder was reduced mobility with 76%. Average gensini score was 60.61±27.51. Intervention technique: incandescent combined with stenting accounted for the highest percentage, at 76%, all using drug-eluting stents, the average number of stents were 1.86±0.93. The success rate of the procedures and coronary angiography was 100%, no Major Adverse Cardiovascular Events have been recorded in hospital, the average time of hospitalization was 10.48±3.86 days. Conclusion: the leading common risk factor for coronary artery disease is hypertension, the majority of patients with typical coronary chest pain, the most common clinical form is acute myocardial infarction, percutaneous coronary intervention for multiple coronary artery disease is a safe treatment. 

Article Details

References

1. Huỳnh Trung Cang (2014). Kết quả 2 năm can thiệp động mạch vành qua da tại Bệnh viện Đa khoa Kiên Giang. Tạp chí tim mạch học Việt Nam, số 68, 161-169.
2. Đỗ Quang Huân và Hồ Huỳnh Quang Trí (2018), Phác đồ điều trị 2018 viện tim Thành phố Hồ Chí Minh, Nhà xuất bản Y học.
3. Phạm Thị Thanh Tâm, Nguyễn Văn Tân và Hồ Thượng Dũng (2017). Nghiên cứu đặc điểm tổn thương động mạch vành ở bệnh nhân hội chứng mạch vành cấp rất cao tuổi. Y học Thành phố Hồ Chí Minh, Phụ bản 21, số 1, 199-204.
4. Zimarino M., Curzen N., Cicchitti V. et al (2013). The adequacy of myocardial revascularization in patients with multivessel coronary artery disease. International Journal of Cardiology, 168(3),1748-1757.
5. Spadaccio C., and Benedetto U. (2018). Coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in the treatment of multivessel coronary disease: quo vadis?-a review of the evidences on coronary artery disease, Annals of cardiothoracic surgery, 7(4), 506-515.